On January 12, 2024, Scinai Immunotherapeutics Ltd. closed the transaction. The transaction included participation from a single investor
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.4578 USD | +1.74% | -1.76% | -23.11% |
1st Jan change | Capi. | |
---|---|---|
-23.11% | 1.99M | |
+1.51% | 42.75B | |
+48.15% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- SCNI Stock
- News Scinai Immunotherapeutics Ltd.
- Scinai Immunotherapeutics Ltd. announced that it has received $1.694259 million in funding